INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Ability to speak and understand English           │ Ability to speak and understand English            │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ability to speak and understand English           │ Ability to speak and understand English            │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ability to speak and understand English           │ Ability to speak and understand English            │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Malabsorptive GI disease, such as celiac disease, │ Malabsorptive GI disease, such as celiac disease,  │     100 │
│ or gastric bypass                                 │ or gastric bypass                                  │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Significant hepatic disease                       │ Significant hepatic disease                        │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant females                                  │ Pregnant females                                   │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Malabsorptive GI disease, such as celiac disease, │ Malabsorptive GI disease, such as celiac disease,  │     100 │
│ or gastric bypass                                 │ or gastric bypass                                  │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Significant hepatic disease                       │ Significant hepatic disease                        │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant females                                  │ Pregnant females                                   │     100 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body Mass Index (BMI) 25-40.0 kg/m2               │ Body Mass Index (BMI) = 35 kg/m2                   │      87 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body Mass Index (BMI) 25-40.0 kg/m2               │ Body Mass Index (BMI) = 35 kg/m2                   │      87 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Untreated anemia (hematocrit \< 34%) as measured  │ Anemia (hematocrit < 34%) as measured at screening │      89 │
│ at screening visit                                │ visit                                              │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Untreated anemia (hematocrit \< 34%) as measured  │ Anemia (hematocrit < 34%) as measured at screening │      89 │
│ at screening visit                                │ visit                                              │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Apparent sensitivity to any study peptides as     │ Apparent sensitivity to any of the study peptides  │      95 │
│ determined by the skin test                       │ as determined by the skin test                     │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Apparent sensitivity to any study peptides as     │ Apparent sensitivity to any of the study peptides  │      95 │
│ determined by the skin test                       │ as determined by the skin test                     │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ AIM2                                               │ Body Mass Index (BMI) = 35 kg/m2                   │      17 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ AIM2: SELECTION OF HEALTHY SUBJECTS                │ Body Mass Index (BMI) = 35 kg/m2                   │      18 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ AIM3: NON-DIABETIC SUBJECTS                        │ Body Mass Index (BMI) = 35 kg/m2                   │      20 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ AIM3: ALL SUBJECTS                                 │ HbA1c = 5.7%                                       │      20 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ AIM3: DIABETIC Type II SUBJECTS                    │ Body Mass Index (BMI) = 35 kg/m2                   │      25 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis or h/o PTSD                              │ Diabetes or immediate family history of diabetes   │      32 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis or h/o PTSD                              │ Diabetes or immediate family history of diabetes   │      32 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Adults age 18-65 years                             │ Ability to speak and understand English            │      33 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Adults age 18-65 years                             │ Ability to speak and understand English            │      33 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Healthy adults age 20-45 years                     │ Coronary artery disease                            │      38 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years                  │ Rheumatoid arthritis                               │      38 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 65 Years                  │ Rheumatoid arthritis                               │      38 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HbA1c less than or equal to 7.5% plus a diagnosis  │ Apparent sensitivity to any of the study peptides  │      40 │
│ of Type II diabetes managed by either Metformin,   │ as determined by the skin test                     │         │
│ Sulfonylurea, or diet and exercise                 │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Uncontrolled high blood pressure                   │ Significant hepatic disease                        │      41 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Uncontrolled high blood pressure                   │ Significant hepatic disease                        │      41 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Lung disease or COPD                               │ Coronary artery disease                            │      42 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Lung disease or COPD                               │ Coronary artery disease                            │      42 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active substance abuse                             │ Congestive heart failure                           │      43 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Chronic use of oral steroid medications such as    │ Malabsorptive GI disease, such as celiac disease,  │      43 │
│ prednisone and hydrocortisone                      │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active substance abuse                             │ Congestive heart failure                           │      43 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Chronic use of oral steroid medications such as    │ Malabsorptive GI disease, such as celiac disease,  │      43 │
│ prednisone and hydrocortisone                      │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active mental health disorders such as depression, │ Malabsorptive GI disease, such as celiac disease,  │      44 │
│ or as a result of Traumatic Brain Injury (TBI)     │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active mental health disorders such as depression, │ Malabsorptive GI disease, such as celiac disease,  │      44 │
│ or as a result of Traumatic Brain Injury (TBI)     │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Evidence of active heart disease, unstable angina  │ Malabsorptive GI disease, such as celiac disease,  │      45 │
│ or heart failure                                   │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Evidence of active heart disease, unstable angina  │ Malabsorptive GI disease, such as celiac disease,  │      45 │
│ or heart failure                                   │ or gastric bypass                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ No Diabetes or use of diabetes medications such as │ Diabetes or immediate family history of diabetes   │      50 │
│ insulin or metformin                               │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diabetes or use of diabetes medications such as    │ Diabetes or immediate family history of diabetes   │      52 │
│ insulin or metformin                               │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HbA1c less than or equal to 5.7% as measured at    │ Anemia (hematocrit < 34%) as measured at screening │      69 │
│ screening visit                                    │ visit                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HbA1c less than or equal to 6.5% as measured at    │ Anemia (hematocrit < 34%) as measured at screening │      69 │
│ screening visit                                    │ visit                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body Mass Index (BMI) less than or equal to 35.0   │ Body Mass Index (BMI) = 35 kg/m2                   │      72 │
│ kg/m2                                              │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Kidney disease or renal insufficiency (eGFR \< 60  │ Renal insufficiency (eGFR < 60 mL/kg/min)          │      79 │
│ mL/kg/min)                                         │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Kidney disease or renal insufficiency (eGFR \< 60  │ Renal insufficiency (eGFR < 60 mL/kg/min)          │      79 │
│ mL/kg/min)                                         │                                                    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                     │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ HbA1c less than or equal to 5.7% as measured at    │ HbA1c = 5.7%                                      │      29 │
│ screening visit                                    │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years                  │ Rheumatoid arthritis                              │      38 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Lung disease or COPD                               │ Pulmonary disorders, including COPD and asthma    │      42 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ No Diabetes or use of diabetes medications such as │ Consumption or injection of insulin               │      42 │
│ insulin or metformin                               │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Chronic use of oral steroid medications such as    │ Consumption of daily medications that alter       │      43 │
│ prednisone and hydrocortisone                      │ glucose metabolism of GI function                 │         │
│                                                    │ (glucocorticoids, psychotropics, narcotics,       │         │
│                                                    │ metoclopramide)                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Active mental health disorders such as depression, │ Diagnosis or h/o PTSD, depression, substance use, │      43 │
│ or as a result of Traumatic Brain Injury (TBI)     │ mental health problems, sleep disorders, HPA      │         │
│                                                    │ disruption and/or TBI                             │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Evidence of active heart disease, unstable angina  │ Congestive heart failure                          │      44 │
│ or heart failure                                   │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Diabetes or use of diabetes medications such as    │ Diabetes or immediate family history of diabetes  │      52 │
│ insulin or metformin                               │                                                   │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Significant hepatic disease                        │ Coronary artery disease                           │      52 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Kidney disease or renal insufficiency (eGFR \< 60  │ Renal insufficiency (eGFR < 60 mL/kg/min)         │      79 │
│ mL/kg/min)                                         │                                                   │         │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 45
Average Levenshtein Ratio of individual lines: 57.473684210526315
OverAll Ratio: 51.23684210526316
